adplus-dvertising
Connect with us

Business

Pfizer presses Health Canada to increase doses taken from each vial – The Globe and Mail

Published

 on


A health-care worker prepares a dose of the Pfizer-BioNTech COVID-19 vaccine at a UHN COVID-19 vaccine clinic in Toronto on Jan. 7, 2021.

Nathan Denette/The Canadian Press

Pfizer-BioNTech is pushing Health Canada to amend its COVID-19 vaccine label and formally recognize that each vial contains six doses rather than five, which would allow the company to send fewer vials to Canada but could complicate the vaccination program.

Pfizer submitted a request to Health Canada on Friday to amend the vaccine label, company spokesperson Christina Antoniou said on Tuesday. The company’s contract with Canada is based on delivering doses, rather than a set number of vials, she said.

“Obtaining six doses from the current multi-dose vial … can help minimize vaccine wastage and enable the most efficient use of the vaccine,” she said.

Story continues below advertisement

Canada-China vaccine collaboration began to fall apart days after Ottawa announced clinical trials

How many coronavirus cases are there in Canada, by province, and worldwide? The latest maps and charts

COVID-19 news: Updates and essential resources about the pandemic

Medical staff in Canada have sometimes been able to withdraw six doses, but officials have said it’s not consistent. However, Pfizer said with specialized syringes, a sixth dose can be reliably pulled from each vial. These syringes are in short supply around the world.

The United States and European Union have already accepted the requested change.

Canada is buying 40 million doses from Pfizer. If Health Canada approves the change, Canada could get about 6.7 million vials rather than eight million. The change could increase the number of people who can receive the vaccine worldwide. However, it could also be a challenge for Canada’s vaccination program, which has already hit several speed bumps.

SQUEEZING EVERY LAST DROP

Each dose of Pfizer’s COVID-19 vaccine must be 0.3 ml. The company says if low-dead space syringes are used then six doses can be withdrawn from each vial of the vaccine. However, if standard syringes are used then medical professionals may only be able to extract five doses.

High-dead space syringe

0.092 ml of fluid retained

Low-dead space syringe

THE GLOBE AND MAIL, SOURCE:

PUBLIC HEALTH ENGLAND

SQUEEZING EVERY LAST DROP

Each dose of Pfizer’s COVID-19 vaccine must be 0.3 ml. The company says if low-dead space syringes are used then six doses can be withdrawn from each vial of the vaccine. However, if standard syringes are used then medical professionals may only be able to extract five doses.

High-dead space syringe

0.092 ml of fluid retained

Low-dead space syringe

THE GLOBE AND MAIL, SOURCE: PUBLIC HEALTH ENGLAND

SQUEEZING EVERY LAST DROP

Each dose of Pfizer’s COVID-19 vaccine must be 0.3 ml. The company says if low-dead space syringes are used then six doses can be withdrawn from each vial of the vaccine. However, if standard syringes are used then medical professionals may only be able to extract five doses.

High-dead space syringe

0.092 ml of fluid retained

Low-dead space syringe

THE GLOBE AND MAIL, SOURCE: PUBLIC HEALTH ENGLAND

Shipments from Pfizer have had delays, and Canada will get no shots this week. Officials hope vaccine candidates from Johnson & Johnson and AstraZeneca will soon be approved in Canada, but so far no delivery is expected before April.

A spokesperson for Procurement Minister Anita Anand said she could not comment until Health Canada decides whether to change the product information.

Late Tuesday, Martin Bégin, a spokesperson for Health Canada, confirmed the regulator has received Pfizer’s request. He was unable to provide a timeline for a decision.

In a statement to The Globe on Monday, Health Canada spokesperson Maryse Durette said the extra volume per vial acts as “a safeguard against potential loss of volume that can occur during storage, preparation and administration of the vaccine, and can result in overages that may amount to an extra dose or two. The monograph of the product would not change because of extra volume in the vial.”

Story continues below advertisement

If health professionals use what’s called a low dead space syringe to extract each dose, Ms. Antoniou said, six doses can be consistently drawn. Dead space is vaccine that is left in a syringe after an injection. “If standard syringes and needles are used, there may not be sufficient volume to extract a sixth dose from a single vial,” Ms. Antoniou said. Some needles can limit dead space.

Pfizer did not provide The Globe with the data to show how often six doses are retrieved from a vial. The Globe asked the Ontario, B.C. and Quebec governments, but they did not provide such information.

The low dead space syringes are a “niche” item, said Troy Kirkpatrick, a spokesperson for BD, the medical technology company supplying the United States with syringes. BD is selling syringes to Canada, but not low dead space ones. The federal government was unable to tell The Globe which company supplies those.

Of the 145 million syringes Canada has bought for the vaccination program, 37.5 million are the kind that would be required if Health Canada approves Pfizer’s request, Ms. Anand’s office said. Her office was unable to say on Tuesday when they would all be delivered.

Ms. Antoniou said six low dead space syringes are needed for each vial.

Until now, the syringes “have historically had low demand,” Mr. Kirkpatrick said, and “no vaccine manufacturer identified the need for these types of devices when production capacity was increased.” He said the company is meeting its current contracts, and advising governments it will “take time” to increase production.

Story continues below advertisement

Canada has also bought 40 million vaccine doses from Moderna. On Tuesday, the company said its shots require standard syringes.

At the University Health Network in Toronto, one of Canada’s largest hospital groups, Emily Musing, a vice-president and professional pharmacist, said staff have been able to “more consistently” get a sixth dose when using a one-milliliter syringe.

However, the hospital ran out and had to use three-ml syringes. “We found with the larger syringes, we were not able to pull up as many sixth doses,” she said.

Neither of those is as reliable as the low dead space syringe, Ms. Antoniou said.

Even without the requirement for the specialized syringe, some public health units were facing supply challenges. In Ontario, one health unit is asking pet clinics for syringes that are specialized enough to get a sixth dose from a vial.

“With an aim to maximize the efficiency of our approach to vaccine delivery, we have reached out to local veterinary clinics and community partners to ask for contributions of syringes,” said Piotr Oglaza, medical officer of health at Hastings Prince Edward public health, which includes the city of Belleville.

Story continues below advertisement

Andrew Blais, who works for a pet hospital in the region, said he was shocked to receive a request from the health unit on Monday for the clinic to donate 1 cc-size syringes. “It felt outrageous that they were even thinking about veterinary clinics,” he said. “I would have thought maybe they would start with public health agencies or other government-funded [agencies].”

“There was definitely a feeling of panic to it,” he said.

Alexandra Hilkene, a spokeswoman for Ontario Health Minister Christine Elliott, said it’s Ottawa’s responsibility to procure syringes for vaccinations. However, she said the province can get additional supplies to help local public health units. She said Ontario sent three-ml syringes to Hastings Prince Edward on Jan. 22 and 25 for a total of 1,000. But those are not the specialized syringes to extract six doses.

Alberta’s health authority said it is buying low dead space syringes and other supplies to supplement shipments from Ottawa.

The federal government has not disclosed how much it is paying Pfizer for the vaccines. A New York Times report suggests that the reduction in vials shipped by Pfizer won’t change how much the U.S. pays. Reuters reports that Sweden is withholding payment until it gets clarity on Pfizer’s billings. The company told a local newspaper it charged for six doses per vial.

With reports from James Keller, Andrea Woo and Les Perreaux.

Story continues below advertisement

Our Morning Update and Evening Update newsletters are written by Globe editors, giving you a concise summary of the day’s most important headlines. Sign up today.

Let’s block ads! (Why?)

728x90x4

Source link

Continue Reading

Business

Telus prioritizing ‘most important customers,’ avoiding ‘unprofitable’ offers: CFO

Published

 on

 

Telus Corp. says it is avoiding offering “unprofitable” discounts as fierce competition in the Canadian telecommunications sector shows no sign of slowing down.

The company said Friday it had fewer net new customers during its third quarter compared with the same time last year, as it copes with increasingly “aggressive marketing and promotional pricing” that is prompting more customers to switch providers.

Telus said it added 347,000 net new customers, down around 14.5 per cent compared with last year. The figure includes 130,000 mobile phone subscribers and 34,000 internet customers, down 30,000 and 3,000, respectively, year-over-year.

The company reported its mobile phone churn rate — a metric measuring subscribers who cancelled their services — was 1.09 per cent in the third quarter, up from 1.03 per cent in the third quarter of 2023. That included a postpaid mobile phone churn rate of 0.90 per cent in its latest quarter.

Telus said its focus is on customer retention through its “industry-leading service and network quality, along with successful promotions and bundled offerings.”

“The customers we have are the most important customers we can get,” said chief financial officer Doug French in an interview.

“We’ve, again, just continued to focus on what matters most to our customers, from a product and customer service perspective, while not loading unprofitable customers.”

Meanwhile, Telus reported its net income attributable to common shares more than doubled during its third quarter.

The telecommunications company said it earned $280 million, up 105.9 per cent from the same three-month period in 2023. Earnings per diluted share for the quarter ended Sept. 30 was 19 cents compared with nine cents a year earlier.

It reported adjusted net income was $413 million, up 10.7 per cent year-over-year from $373 million in the same quarter last year. Operating revenue and other income for the quarter was $5.1 billion, up 1.8 per cent from the previous year.

Mobile phone average revenue per user was $58.85 in the third quarter, a decrease of $2.09 or 3.4 per cent from a year ago. Telus said the drop was attributable to customers signing up for base rate plans with lower prices, along with a decline in overage and roaming revenues.

It said customers are increasingly adopting unlimited data and Canada-U.S. plans which provide higher and more stable ARPU on a monthly basis.

“In a tough operating environment and relative to peers, we view Q3 results that were in line to slightly better than forecast as the best of the bunch,” said RBC analyst Drew McReynolds in a note.

Scotiabank analyst Maher Yaghi added that “the telecom industry in Canada remains very challenging for all players, however, Telus has been able to face these pressures” and still deliver growth.

The Big 3 telecom providers — which also include Rogers Communications Inc. and BCE Inc. — have frequently stressed that the market has grown more competitive in recent years, especially after the closing of Quebecor Inc.’s purchase of Freedom Mobile in April 2023.

Hailed as a fourth national carrier, Quebecor has invested in enhancements to Freedom’s network while offering more affordable plans as part of a set of commitments it was mandated by Ottawa to agree to.

The cost of telephone services in September was down eight per cent compared with a year earlier, according to Statistics Canada’s most recent inflation report last month.

“I think competition has been and continues to be, I’d say, quite intense in Canada, and we’ve obviously had to just manage our business the way we see fit,” said French.

Asked how long that environment could last, he said that’s out of Telus’ hands.

“What I can control, though, is how we go to market and how we lead with our products,” he said.

“I think the conditions within the market will have to adjust accordingly over time. We’ve continued to focus on digitization, continued to bring our cost structure down to compete, irrespective of the price and the current market conditions.”

Still, Canada’s telecom regulator continues to warn providers about customers facing more charges on their cellphone and internet bills.

On Tuesday, CRTC vice-president of consumer, analytics and strategy Scott Hutton called on providers to ensure they clearly inform their customers of charges such as early cancellation fees.

That followed statements from the regulator in recent weeks cautioning against rising international roaming fees and “surprise” price increases being found on their bills.

Hutton said the CRTC plans to launch public consultations in the coming weeks that will focus “on ensuring that information is clear and consistent, making it easier to compare offers and switch services or providers.”

“The CRTC is concerned with recent trends, which suggest that Canadians may not be benefiting from the full protections of our codes,” he said.

“We will continue to monitor developments and will take further action if our codes are not being followed.”

French said any initiative to boost transparency is a step in the right direction.

“I can’t say we are perfect across the board, but what I can say is we are absolutely taking it under consideration and trying to be the best at communicating with our customers,” he said.

“I think everyone looking in the mirror would say there’s room for improvement.”

This report by The Canadian Press was first published Nov. 8, 2024.

Companies in this story: (TSX:T)

Source link

Continue Reading

Business

TC Energy cuts cost estimate for Southeast Gateway pipeline project in Mexico

Published

 on

 

CALGARY – TC Energy Corp. has lowered the estimated cost of its Southeast Gateway pipeline project in Mexico.

It says it now expects the project to cost between US$3.9 billion and US$4.1 billion compared with its original estimate of US$4.5 billion.

The change came as the company reported a third-quarter profit attributable to common shareholders of C$1.46 billion or $1.40 per share compared with a loss of C$197 million or 19 cents per share in the same quarter last year.

Revenue for the quarter ended Sept. 30 totalled C$4.08 billion, up from C$3.94 billion in the third quarter of 2023.

TC Energy says its comparable earnings for its latest quarter amounted to C$1.03 per share compared with C$1.00 per share a year earlier.

The average analyst estimate had been for a profit of 95 cents per share, according to LSEG Data & Analytics.

This report by The Canadian Press was first published Nov. 7, 2024.

Companies in this story: (TSX:TRP)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

BCE reports Q3 loss on asset impairment charge, cuts revenue guidance

Published

 on

 

BCE Inc. reported a loss in its latest quarter as it recorded $2.11 billion in asset impairment charges, mainly related to Bell Media’s TV and radio properties.

The company says its net loss attributable to common shareholders amounted to $1.24 billion or $1.36 per share for the quarter ended Sept. 30 compared with a profit of $640 million or 70 cents per share a year earlier.

On an adjusted basis, BCE says it earned 75 cents per share in its latest quarter compared with an adjusted profit of 81 cents per share in the same quarter last year.

“Bell’s results for the third quarter demonstrate that we are disciplined in our pursuit of profitable growth in an intensely competitive environment,” BCE chief executive Mirko Bibic said in a statement.

“Our focus this quarter, and throughout 2024, has been to attract higher-margin subscribers and reduce costs to help offset short-term revenue impacts from sustained competitive pricing pressures, slow economic growth and a media advertising market that is in transition.”

Operating revenue for the quarter totalled $5.97 billion, down from $6.08 billion in its third quarter of 2023.

BCE also said it now expects its revenue for 2024 to fall about 1.5 per cent compared with earlier guidance for an increase of zero to four per cent.

The company says the change comes as it faces lower-than-anticipated wireless product revenue and sustained pressure on wireless prices.

BCE added 33,111 net postpaid mobile phone subscribers, down 76.8 per cent from the same period last year, which was the company’s second-best performance on the metric since 2010.

It says the drop was driven by higher customer churn — a measure of subscribers who cancelled their service — amid greater competitive activity and promotional offer intensity. BCE’s monthly churn rate for the category was 1.28 per cent, up from 1.1 per cent during its previous third quarter.

The company also saw 11.6 per cent fewer gross subscriber activations “due to more targeted promotional offers and mobile device discounting compared to last year.”

Bell’s wireless mobile phone average revenue per user was $58.26, down 3.4 per cent from $60.28 in the third quarter of the prior year.

This report by The Canadian Press was first published Nov. 7, 2024.

Companies in this story: (TSX:BCE)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending